Health
Foresight Diagnostics demonstrates the benefits of PhasED-Seq technology at the ICML meeting – News-Medical.Net – Fior Reports
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical…
Foresight Diagnostics, the emerging leader in the monitoring of blood-based lymphoma diseases, announced today that the clinical performance of its Minimal Residual Disease Detection Platform (MRD) in Diffuse B-Cell Large Cell Lymphoma (DLBCL) will be presented…
Continue Reading
-
Noosa News14 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General12 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News13 hours agoLyka Doggie Date Night at Moonlight Cinema
-
Business15 hours agoSolid superannuation gains continue to roll in